MedPath

Sleep electroencephalogram (EEG) recordings in interferon-alpha treated hepatitis C patients – Pilot Study

Not Applicable
Recruiting
Conditions
Mood side effects of interferon alpha treatment
Mood effects of interferon treatment of hepatitis C patients
Mental Health - Depression
Registration Number
ACTRN12608000526370
Lead Sponsor
nited Hospitals Bristol
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
15
Inclusion Criteria

Hepatitis C, receiving interferon alpha treatment.

Exclusion Criteria

Current mental illness or drug/alcohol abuse at baseline. History of schizophrenia or bipolar affective disorder. Current unstable medical illness. Taking medicine that affect sleep EEG measures (antidepressants). Current occupational history of nightshift working

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Sleep EEG changes: Rapid Eye Movement latency and sleep fragmentation[Baseline and 6 weeks.]
Secondary Outcome Measures
NameTimeMethod
Mood changes: Depression, Becks Depression Inventory, visual analogue scales.[baseline and 6 weeks];Mood changes: anxiety, speilberger state/trait anxiety inventory, panic state inventory, visual analogue scales[Baesline and 6 weeks];Mood changes: irritability, spielberger state/trait anger expression inventory, visual analogue scales.[Baseline and six weeks.];Psychiatric diagnosis: revised clinical interview schedule (CIS-R), also clinical diagnosis by a study psychiatrist[Baseline and week 6. Any timepoint for duration of interferon treatment (the duration of interferon treatment is decided by the treating team independant from the study. It is usually either 6 months or 12 months duration depending upon the genotype of hepatitis C and the early response, measured by plasma viral load, to treatment.]
© Copyright 2025. All Rights Reserved by MedPath